Purpose: The dose of radiation that locally controls human tumors trea
ted electively or for gross disease is rarely well defined, These dose
s can be useful in understanding the dose requirements of novel therap
ies featuring inhomogeneous dosimetry and in an adjuvant setting, The
goal of this study was to compute the dose of radiation that locally c
ontrols 50% (TCD50) of tumors in human subjects. Methods and Materials
: Legit regression was used with data collected from single institutio
ns or from combinations of local control data accumulated from several
institutions treating the same disease. Results: 90 dose response cur
ves were calculated; 62 of macroscopic tumor therapy, 28 of elective t
herapy with surgery for primary control, The mean and median TCD50 for
gross disease were 50.0 and 51.9 Gy, respectively, The mean and media
n TCD50 for microscopic disease control were 39.3 and 37.9 Gy, respect
ively, At the TCD50 an additional dose of 1 Gy controlled an additiona
l 2.5 % (median) additional patients with macroscopic disease and 4.2%
(median) additional patients with microscopic disease, For both macro
-and microscopic disease, an increase of 1% of dose at the TCD50 incre
ased control rates approximate to 1% (median) or 2-3% (mean), A predom
inance of dose response curves had shallow slopes accounting for the d
iscrepancy between mean and median values. Conclusion: Doses to contro
l microscopic disease are approximately 12 Gy less than that required
to control macroscopic disease, and are about 79 % of the dose require
d to control macroscopic disease, The percentage increase in cures exp
ected for a 1% increase in dose is similar for macroscopic and microsc
opic disease, with a median value of approximate to 1%/% and a mean of
approximate to 2.7%/%.